A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects [see comments]

British Journal of Clinical Pharmacology

Volumn 38, Issue 6, 1994, Pages 527-532

  Grove, A ^a   Allam, C ^a   McFarlane, LC ^a   McPhate, G ^a   Jackson, CM ^a   Lipworth, BJ ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BUDESONIDE; FLUTICASONE PROPIONATE; HYDROCORTISONE; OSTEOCALCIN;

ADULT; ARTICLE; BIOAVAILABILITY; BONE METABOLISM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INHALATIONAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ADULT; ALKALINE PHOSPHATASE; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL AVAILABILITY; BONE AND BONES; BUDESONIDE; CALCIUM; CROSS-OVER STUDIES; FEMALE; HUMANS; HYDROCORTISONE; MALE; OSTEOCALCIN; PREGNENEDIONES; SINGLE-BLIND METHOD;

EID: 0027942555     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.1994.tb04394.x     Document Type: Article

References (22)

1. a summary
2. Clinical pharmacology of inhaled corticosteroids in bronchial asthma
3. Equipotency of budesonide and fluticasone propionate in the vasoconstriction assay
4. Topical and systemic glucocorticoid potencies of budesonide and beclomethasone dipropionate in man
5. Structure‐activity relationships of topically active steroids: the selection of fluticasone propionate
6. Pharmacokinetics and metabolism of budesonide, a selective glucocorticoid
7. The human pharmacology of fluticasone propionate
8. Effect of a volumatic spacer and mouth‐rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhaler
9. Assessment of systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover
10. Bone turnover during high dose inhaled corticosteroid treatment
11. Effect of high‐dose inhaled budesonide on calcium and phosphate metabolism and the risk of osteoporosis
12. Screening for hypothalamo‐pituitary‐adrenal axis suppression in asthmatics taking high‐dose inhaled corticosteroids
13. Effects of dose and dosing schedule of inhaled budesonide on bone turnover
14. A comparison of budesonide and beclomethasone dipropionate on indices of bone turnover in COAD
15. The influence of orally deposited budesonide on the systemic availability of budesonide after inhalation from a turbohaler
16. A sensitive radioimmunoassay, incorporating solid phase extraction, for fluticasone 17‐propionate in plasma
17. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airflow obstruction
18. Lung deposition of budesonide inhaled via Turbohaler: a comparison with terbutaline sulphate in normal subjects
19. Suppressive effect on the HPA‐axis of therapeutic doses of fluticasone propionate in healthy volunteers
20. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year
21. Fluticasone propionate 2.0 mg daily suppresses the hypothalmo pituitary adrenal axis in moderate to severe asthmatics
22. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma